M08.84
Other juvenile arthritis, hand
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a condition affecting children and adolescents that causes inflammation in the joints. When it specifically impacts the hand, it can influence a child's ability to perform daily activities, play, and develop normal hand functions. The ICD-10 code M08.84 refers to cases of juvenile arthritis affecting the hand, emphasizing its specific localization and nature. This condition requires careful management to reduce symptoms and prevent long-term joint damage.
Causes & Symptoms
Clinical Causes: Autoimmune response where the immune system mistakenly attacks the joint tissues in children Genetic factors that may increase susceptibility to early-onset arthritis Environmental triggers, such as infections or other illnesses, which may provoke an immune response Unknown factors in some cases, as with many autoimmune conditions
Key Symptoms: Swelling in the joints of the hand, often bilateral but can be unilateral Persistent or intermittent pain in the affected hand joints Stiffness, especially after periods of rest or in the morning Warmth and redness around the affected joints Reduced range of motion or difficulty moving the fingers or hand Fatigue and general discomfort in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing juvenile arthritis involves a combination of clinical evaluation and diagnostic tests. Healthcare providers typically perform physical examinations to assess joint swelling, tenderness, and movement. Blood tests may be ordered to detect markers of inflammation, such as elevated ESR (erythrocyte sedimentation rate) or CRP (C-reactive protein). Imaging techniques like X-rays, MRI, or ultrasound can help visualize joint inflammation and damage. Since symptoms can mimic other conditions, ruling out infections or other rheumatologic diseases is essential to confirm a diagnosis of juvenile arthritis affecting the hand.
Treatment Protocols: While juvenile arthritis in the hand requires tailored treatment plans, the main goal is to control inflammation, relieve symptoms, and preserve joint function. Common therapies include: - **Nonsteroidal anti-inflammatory drugs (NSAIDs):** To reduce pain and swelling - **Disease-modifying antirheumatic drugs (DMARDs):** Such as methotrexate, to slow disease progression - **Physical and occupational therapy:** To maintain hand strength, flexibility, and function - **Steroid injections:** For localized inflammation control - **Biologic agents:** Targeted therapies for severe cases not responding to standard treatments - **Supportive measures:** Use of splints or assistive devices to aid mobility and daily activities Early intervention and consistent management are critical in preventing joint damage and ensuring better long-term outcomes for children with this condition.
Clinical Advice & FAQs
Billing Guidance
Is M08.84 a billable ICD-10 code?
Yes, M08.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.84?
Clinical documentation must specify the nature of Other juvenile arthritis, hand and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
